Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Glomerular Basement Membrane Antibody Disease”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableLooking for participantsNCT07018024
What this trial is testing

Anti-Glomerular Basement Membrane Disease

Who this might be right for
Anti-Glomerular Basement Membrane Disease
Region Skane 300
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd. 84
Not applicableStudy completedNCT03635385
What this trial is testing

Comparison of ANCA and Anti-GBM Auto-antibodies Removal Kinetics Between Plasma Exchanges and Immunoadsorption in Patients With ANCA-associated Vasculitis or Anti-GBM Disease

Who this might be right for
Kidney Failure, Acute
Assistance Publique Hopitaux De Marseille 40
Testing effectiveness (Phase 2)Study completedNCT06513338
What this trial is testing

Complement C5 mAb in the Treatment of Anti-GBM Disease

Who this might be right for
Autoimmune Diseases
Peking University First Hospital 16
Not applicableStudy completedNCT03664908
What this trial is testing

Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?

Who this might be right for
Lupus Nephritis
CHU de Reims 100
Testing effectiveness (Phase 2)Study completedNCT03157037
What this trial is testing

Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane Antibody Disease
Mårten Segelmark 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06607016
What this trial is testing

A Clinical Trial With KJ103 in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane Disease
Shanghai Bao Pharmaceuticals Co., Ltd. 12
Not applicableStudy completedNCT05894317
What this trial is testing

Vascular Access Complications for Therapeutic Apheresis in Nephrology

Who this might be right for
Vascular Access ComplicationApheresis Related Complication
Central Hospital, Nancy, France 60
Large-scale testing (Phase 3)Ended earlyNCT05679401
What this trial is testing

A Study With Imlifidase in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane DiseaseAnti-Glomerular Basement Membrane Antibody DiseaseGoodpasture Syndrome+1 more
Hansa Biopharma AB 50